ASBP is trading 5.3% up at $5.62 as the stock rebounds from a sharp drop in the prior session linked to concerns over its planned acquisition of Dura Driver Control Systems.

  • Market sentiment is improving as investors refocus on positive news regarding a successful FDA pre-IND meeting for the OTASA sublingual aspirin candidate.
  • The recovery helps offset recent volatility triggered by uncertainty surrounding the acquisition's deal structure and regulatory path.